Adaptive Biotechnologies Corp (ADPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 178,957 | 170,276 | 185,308 | 154,344 | 98,382 |
| Cost of Goods | 72,080 | 75,553 | 57,909 | 49,301 | 22,530 |
| Gross Profit | 106,877 | 94,723 | 127,399 | 105,043 | 75,852 |
| Operating Expenses | 269,506 | 322,311 | 328,494 | 314,310 | 229,199 |
| Operating Income | -162,549 | -227,035 | -200,186 | -208,966 | -152,817 |
| Interest Expense | 11,580 | 13,800 | 4,238 | 0 | 0 |
| Other Income | 14,534 | 15,531 | 4,056 | 1,668 | 6,590 |
| Pre-tax Income | -159,595 | -225,304 | -200,368 | -207,298 | -146,227 |
| Net Income Continuous | -159,595 | -225,304 | -200,368 | -207,298 | -146,227 |
| Minority Interests | -103 | -54 | -177 | -19 | N/A |
| Net Income | $-159,492 | $-225,250 | $-200,191 | $-207,279 | $-146,227 |
| EPS Basic Total Ops | -1.08 | -1.56 | -1.40 | -1.48 | -1.11 |
| EPS Basic Continuous Ops | -1.08 | -1.56 | -1.41 | -1.48 | -1.11 |
| EPS Diluted Total Ops | -1.08 | -1.56 | -1.40 | -1.48 | -1.11 |
| EPS Diluted Continuous Ops | -1.08 | -1.56 | -1.41 | -1.48 | -1.11 |
| EPS Diluted Before Non-Recurring Items | -1.03 | -1.38 | -1.40 | -1.48 | -1.11 |
| EBITDA(a) | $-151,501 | $-213,988 | $-178,525 | $-187,780 | $-143,572 |